Teens with heart disease improve exercise capacity in large clinical trial

The largest-ever clinical trial of a medication for pediatric cardiology patients found that an oral drug significantly improved exercise capacity in adolescent patients with severe, congenital single-ventricle heart defects. A study leader says the physiologic benefits represent a milestone in the care of those who have undergone the Fontan procedure, a palliative operation for single-ventricle disease.

from Top Health News -- ScienceDaily https://ift.tt/2CV3Xjm